View Full Version : Integrity in Biomedical Research

Herman J. Woltring
01-12-1991, 04:44 PM
Dear Biomch-L readers,

As an example of the contents of the APA database mentioned in my previous
posting, and because integrity and due process of funding review was one of
the topics at the ASB funding meeting in Miami, I am posting the following
announcement (NIH INTEG).
As some of you may know, scientific integrity is a hot issue in the US
and elsewhere, following some cases in which inappropriately generated
research results were published. While emphasizing such issues may seem
somewhat negativistic (there are many who think that it's just a big fuss,
and that `scientists' are quite capable of running their show in a proper
manner), public attention for these matters is such that conferences of
this kind seem necessary. If you're interested in reading about some of
the more well-known cases, just subscribe to SCIFRAUD@ALBNYVM1 and/or read
the book "False Prophets -- Fraud and Error in Science and Medicine" by
Alexander Kohn (Basil Blackwell, Oxford/UK & Cambridge/USA, 1986-1989).
The author is Professor of Virology at the Tel Aviv Medical School, and
editor of the Journal of Irreproducible Results.

Regards -- Herman J. Woltring, Eindhoven/NL


P.T. 42; K.W. 1014004, 1014006

National Institutes of Health

The National Institutes of Health, the Association of American Medical
Colleges, and Harvard Medical School are co-sponsoring a working conference
for scientists, administrators, and lawyers who have responsibility for
implementing policies and regulations designed to ensure scientific integrity.
The program is designed for maximum interaction between panelists and
attendees, and among attendees themselves. The goal is to generate new
perspectives for some of the most difficult problems faced by research
institutions in dealing with matters of scientific integrity. The moderators
and panelists will bring the perspectives of law, research, and administration
to the issues of due process for accused, accuser and institution; ownership
of research data; setting sanctions for misconduct; rehabilitation of
scientists found guilty of scientific misconduct; and prevention of scientific
misconduct. Samuel Thier, M.D., President, Institute of Medicine, will
address the conference on the balance between university and government
responsibilities for assurance of scientific integrity.

This conference meets the criteria for 11 credit hours in Category 1 of the
Physician's Recognition Award of the AMA.

DATES: February 2-3, 1991

SITE: Hyatt Regency Hotel, Cambridge, MA



P.T. 42; K.W. 1014004, 1014006

National Institutes of Health

The National Institutes of Health (NIH), the Association of American Medical
Colleges, and Washington University School of Medicine are co-sponsoring an
interactive conference for biomedical investigators, research administrators,
and university attorneys with an interest in fostering the integrity of
scientists. The goals of the workshop are to discuss the scope of the problem
of scientific misconduct; to identify perceived or real factors contributing
to misconduct; to discuss the roles of Congress, NIH, and institutions in
managing allegations of scientific misconduct; to examine how well specific
institutions have dealt with allegations of fraud, plagiarism or other
unacceptable scientific practices; to discuss any special ethical
considerations associated with Industry/University ties; and to discuss the
responsibilities of authors and collaborators in maintaining scientific
integrity in research. Several break-out sessions will address focussed
topics of particular concern.

This conference is approved for credit in AMA Category 1.

DATES: April 25-26, 1991

SITE: The Adams Mark Hotel, St. Louis, MO


Tel.: +1 (800) 325-9862, interstate
+1 (314) 362-6893, in Missouri and abroad